Annual Current Liabilities
$216.42 M
-$81.37 M-27.32%
December 31, 2023
Summary
- As of February 7, 2025, LEGN annual total current liabilities is $216.42 million, with the most recent change of -$81.37 million (-27.32%) on December 31, 2023.
- During the last 3 years, LEGN annual current liabilities has risen by +$100.85 million (+87.27%).
- LEGN annual current liabilities is now -27.32% below its all-time high of $297.79 million, reached on December 31, 2022.
Performance
LEGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$270.89 M
-$23.41 M-7.95%
September 30, 2024
Summary
- As of February 7, 2025, LEGN quarterly total current liabilities is $270.89 million, with the most recent change of -$23.41 million (-7.95%) on September 30, 2024.
- Over the past year, LEGN quarterly current liabilities has increased by +$54.48 million (+25.17%).
- LEGN quarterly current liabilities is now -9.03% below its all-time high of $297.79 million, reached on December 31, 2022.
Performance
LEGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LEGN Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.3% | +25.2% |
3 y3 years | +87.3% | +25.2% |
5 y5 years | +36.0% | +25.2% |
LEGN Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.3% | at low | -9.0% | +54.6% |
5 y | 5-year | -27.3% | +87.3% | -9.0% | +140.9% |
alltime | all time | -27.3% | +87.3% | -9.0% | +140.9% |
Legend Biotech Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $270.89 M(-8.0%) |
Jun 2024 | - | $294.30 M(+17.9%) |
Mar 2024 | - | $249.68 M(+15.4%) |
Dec 2023 | $216.42 M(-27.3%) | $216.42 M(+23.5%) |
Sep 2023 | - | $175.22 M(-13.0%) |
Jun 2023 | - | $201.38 M(-15.5%) |
Mar 2023 | - | $238.18 M(-20.0%) |
Dec 2022 | $297.79 M | $297.79 M(+14.6%) |
Jun 2022 | - | $259.76 M(+15.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $225.53 M(-1.6%) |
Dec 2021 | $229.20 M(+98.3%) | $229.20 M(-16.8%) |
Sep 2021 | - | $275.37 M(+88.7%) |
Mar 2021 | - | $145.94 M(+26.3%) |
Dec 2020 | $115.57 M(-9.5%) | $115.57 M(-6.4%) |
Sep 2020 | - | $123.52 M(+7.4%) |
Jun 2020 | - | $115.03 M(+2.3%) |
Mar 2020 | - | $112.43 M(-12.0%) |
Dec 2019 | $127.76 M(-19.7%) | $127.76 M |
Dec 2018 | $159.19 M | - |
FAQ
- What is Legend Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Legend Biotech?
- What is Legend Biotech annual current liabilities year-on-year change?
- What is Legend Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Legend Biotech?
- What is Legend Biotech quarterly current liabilities year-on-year change?
What is Legend Biotech annual total current liabilities?
The current annual current liabilities of LEGN is $216.42 M
What is the all time high annual current liabilities for Legend Biotech?
Legend Biotech all-time high annual total current liabilities is $297.79 M
What is Legend Biotech annual current liabilities year-on-year change?
Over the past year, LEGN annual total current liabilities has changed by -$81.37 M (-27.32%)
What is Legend Biotech quarterly total current liabilities?
The current quarterly current liabilities of LEGN is $270.89 M
What is the all time high quarterly current liabilities for Legend Biotech?
Legend Biotech all-time high quarterly total current liabilities is $297.79 M
What is Legend Biotech quarterly current liabilities year-on-year change?
Over the past year, LEGN quarterly total current liabilities has changed by +$54.48 M (+25.17%)